Literature DB >> 26828228

Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity.

Ricardo Jorge Dinis-Oliveira1,2,3.   

Abstract

Cannabis sativa is the most commonly used recreational drug, Δ(9)-tetrahydrocannabinol (Δ(9)-THC) being the main addictive compound. Biotransformation of cannabinoids is an important field of xenobiochemistry and toxicology and the study of the metabolism can lead to the discovery of new compounds, unknown metabolites with unique structures and new therapeutic effects. The pharmacokinetics of Δ(9)-THC is dependent on multiple factors such as physical/chemical form, route of administration, genetics, and concurrent consumption of alcohol. This review aims to discuss metabolomics of Δ(9)-THC, namely by presenting all known metabolites of Δ(9)-THC described both in vitro and in vivo, and their roles in the Δ(9)-THC-mediated toxic effects. Since medicinal use is increasing, metabolomics of Δ(9)-THC will also be discussed in order to uncover potential active metabolites that can be made available for this purpose.

Entities:  

Keywords:  Cannabis; metabolomics; pharmacokinetics; toxicity; Δ9-tetrahydrocannabinol

Mesh:

Substances:

Year:  2016        PMID: 26828228     DOI: 10.3109/03602532.2015.1137307

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  18 in total

1.  Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Authors:  Laura M Dryburgh; Nanthi S Bolan; Christopher P L Grof; Peter Galettis; Jennifer Schneider; Catherine J Lucas; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-08-01       Impact factor: 4.335

Review 2.  Cannabis use during pregnancy: Pharmacokinetics and effects on child development.

Authors:  Kimberly S Grant; Rebekah Petroff; Nina Isoherranen; Nephi Stella; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2017-08-25       Impact factor: 12.310

Review 3.  Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.

Authors:  Ricardo Jorge Dinis-Oliveira; Carolina Lança Pereira; Diana Dias da Silva
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

4.  Quantifying Hepatic Enzyme Kinetics of (-)-∆9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, 11-OH-THC, through In Vitro Modeling.

Authors:  Gabriela I Patilea-Vrana; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2019-05-02       Impact factor: 3.922

Review 5.  Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version.

Authors:  Jiaxi Xie; Cailing Zhong; Tingting Wang; Dan He; Luyang Lu; Jie Yang; Ziyi Yuan; Jingqing Zhang
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 6.  The pharmacokinetics and the pharmacodynamics of cannabinoids.

Authors:  Catherine J Lucas; Peter Galettis; Jennifer Schneider
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

Review 7.  Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug.

Authors:  Shiri Procaccia; Gil Moshe Lewitus; Carni Lipson Feder; Anna Shapira; Paula Berman; David Meiri
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

Review 8.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

Review 9.  Metabolism and metabolomics of ketamine: a toxicological approach.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Forensic Sci Res       Date:  2017-02-20

10.  Irinotecan and Δ⁸-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers.

Authors:  Ana Lucić Vrdoljak; Nino Fuchs; Anja Mikolić; Suzana Žunec; Irena Brčić Karačonji; Andreja Jurič; Ljerka Prester; Vedran Micek; Marijana Neuberg; Samir Čanović; Gordan Mršić; Nevenka Kopjar
Journal:  Molecules       Date:  2018-06-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.